US Patent Issued to NINEBIOPHARM on April 21 for "Regentide-041 and composition comprising Regentide-041 for improving skin condition" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,595, issued on April 21, was assigned to NINEBIOPHARM Co. LTD. (Cheongju-si, South Korea).

"Regentide-041 and composition comprising Regentide-041 for improving skin condition" was invented by Jae Hwan Kim (Sejong-si, South Korea), Ji Heon Rhim (Sejong-si, South Korea), Hye In Ahn (Cheongju-si, South Korea), Ri Ra Lee (Gwangju-si, South Korea) and Hae Yeong Kang (Cheongju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Regentide-041 and, more specifically, to a use of Regentide-041 for improving skin conditions. Regentide-041 according to the present invention is free of cytotoxicity and has remarkabl...